<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.14127</field>
		<field name="filename">20394_02%20-%20conclusao_referencias%20bibliograficas.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
 81

5. CONCLUSÃO 

As estirpes de Bifidobacterium breve (UFVCC 1083, UFVCC 1091, 

UFVCC 1099, UFVCC 1103, UFVCC 1105, UFVCC 1108 e UFVCC 1111) de 

origem humana, utilizadas na presente experimentação, não promoveram 

efeitos adversos na saúde geral dos animais testados, uma vez que não 

induziram toxicidade oral crônica (não promovendo crescimento anormal do 

fígado, rins, coração e baço dos animais estudados) e nem promoveram 

translocação de bacterias do trato gastrointestinal para outros órgãos após 

21 dias de tratamento. No entanto, recomenda-se a realização da mesma 

experimentação com outros mamíferos, incluindo humanos sadios, antes da 

implantação dessas estirpes nos bancos de leite humano. Recomenda-se 

também, verificar a toxicidade oral aguda, ministrando concentrações mais 

elevadas do pool probiótico por um menor tempo.  



 82

CONCLUSÃO GERAL 

As 31 estirpes de Bifidobacterium breve isoladas de recém-nascidos 

apresentaram susceptibilidade variável aos 14 antibióticos avaliados, 

sugerindo que este fenótipo é estirpe dependente. No entanto, observou-se 

que a maioria das estirpes foram sensíveis aos antimicrobianos, o que é 

uma característica de segurança importante no processo de seleção desses 

isolados para uso como probiótico em bancos de leite humano, devido a 

possibilidade de transferência do genes de resistência no ambiente 

intestinal.  

Os isolados de Bifidobacterium breve avaliados nesta experimentação 

apresentaram uma variabilidade na sua ação antagonista sobre Clostridium 

difficile, Staphylococcus aureus, Escherichia coli, Salmonella typhimurium e 

Listeria monocytogenes pelo método “spot”. Verificou-se também que essa 

inibição foi estirpe dependente e não promovida somente por ácidos 

orgânicos, uma vez que não foi totalmente revertida quando utilizou-se meio 

tamponado. O efeito da substância inibitória somente foi detectado em meio 

sólido (método “spot”), sugerindo a necesidade de um fator de indução, 

como por exemplo, o contato com o microrganismo patogênico, para que 

esse seja expresso. Essa experimentação corrobora a necessidade de 

utilização de mais de uma técnica na avaliação do efeito antagonista de 

bactérias probióticas sobre patógenos, uma vez que os mecanismos 

envolvidos no antagonismo são diferentes. 

As estirpes de Bifidobacterium breve de origem humana selecionadas 

para composição do pool probiótico (UFVCC 1083, UFVCC 1091, UFVCC 

1099, UFVCC 1103, UFVCC 1105, UFVCC 1108 e UFVCC 1111), utilizadas 

na presente experimentação, não promoveram efeitos adversos na saúde 

geral dos animais testados, uma vez que não induziram toxicidade oral 

crônica (não promovendo crescimento anormal do fígado, rins, coração e 

baço dos animais estudados) e nem promoveram translocação de bacterias 

do trato gastrointestinal para outros órgãos após 21 dias de tratamento. No 

entanto, recomenda-se a realização da mesma experimentação com outros 

mamíferos, incluindo humanos sadios, antes da implantação dessas estirpes 

nos bancos de leite humano. Recomenda-se também, verificar a toxicidade 



 83

oral aguda, ministrando concentrações mais elevadas do pool probiótico por 

um menor tempo.  



 84

 

REFERÊNCIAS BIBLIOGRÁFICAS 

ABEE, T., ROMBOUTS, F. M., HUGENHOLTZ, J., GUIHARD, G. &amp;amp; 

LETELLIER, L. Mode of action of nisin Z against Listeria monocytogenes 

Scott A grown at high and low temperatures. Appl. Environ. Microbial., 

60, 1962-1968. 1994. 

ADAWI, D., AHRNÉ, S., GÕRAN, M. Effects of different probiotic strains of 

Lactobacillus and Bifidobacterium on bacterial translocation and liver 

injury in na acute liver injury model. International Journal of Food 

Microbiology 70, 213-220, 2001. 

ALAKOMI, H. L., SKYTTA, E., SAARELA, M., MATTILA-SANDHOLM, T., 

LATVA-KALA, K., HELANDER, I. M. Lactic acid permeabilizes gram-

nagative bacteria by disrupting the outer membrane. Appl. Environ. 

Microbial, 66, 2001-2005, 2000. 

AL-LAWATI, A., CROUCH,  N.D. AND ELHAG,  K. M, Antibiotic consumption 

and development of resistance among gram-negative bacilli in intensive 

care units in Oman.  Annals of Saudi Medicine,   20(2-3):324-327. 

2000. 

AMANT, D.C., VALENTIN-BON, I.E. AND JERSE, A.E. Inhibition of Neisseria 

gonorrhoeae by Lactobacillus species that are commonly isolated from 

the female genital tract. Infect. Immun. 70, 7169–7171, 2002. 

ARAKI, T., SHINOZAKI, T., IRIE, Y., &amp;amp; MIYAZAWA, Y., Trial of oral 

administration os Bifidobacterium breve for the prevention of rotavirus 

infection. Jornal of Japanese Association of Infectius Diseases 1999., 73: 

305-310. In: HARSHARNJIT, S.G., Probiotics to enhance anti-infective 

defences in the gastrointestinal tract. Nutrition Research. VOL 17, Nº5, p. 

755-773, 2003. 

ARANOW, J. S., FINK, M. P. Determinants of intestinal barrier failure in 

critical illness. British Journal of Anaesthesia, 77: 71-81, 1996. 

ARNOLD, L. D.W., LARSON, E. Immunologic beneffts of breast milk in 

relation to human milk banking. American Journal Infect Control 21, 

235-242, 1993. 



 85

AROUTCHEVA, A., GARITI, D., SIMON, M., SHOTT, S., FARO, J., SIMOES, 

J.A., GURGUIS, A. AND FARO, S. Defense factors of vaginal lactobacilli. 

Am. J. Obstet. Gynecol. 185, 375–379, 2001. 

ARUNACHALAM, K. D., Role of Bifidobacteria in nutrition, Medicine and 

Technology. Nutrition Research Vol 19. Nº 10 pp.1559-1597, 1999. 

ASAHARA, T., NOMOTO, K., WATANUKI, M. AND YOKOKURA, T. 

Antimicrobial activity of intraurethrally administered probiotic 

Lactobacillus casei in a murine model of Escherichia coli urinary tract 

infection. Antimicrob. Agents Chemother. 45, 1751–1760, 2001. 

AUSTIN, D. J., KRISTINSSON, K. G., ANDERSON, R. M. The relationship 

between the volume of antimicrobial consumption in human communities 

and the frequency of resistance. PNAS 96, 1152–1156, 1999. 

BARBOSA, H.M, TORRES B.B, FURLANETO M.C. Microbiologia Básica. 

Ed. Atheneu, São Paulo, 1998. 

BAWER, A.W., KIRLY. W. M. M, SHERRIS, J. C., TURK, M., Antibiotic 

susceptibility testing by standardized single disk method. American 

Journal of Clinical Pathology 45, 493-493, 1966. 

BAYER, A. S., CHOW, A. W., BETTS, D. AND GUZE, L. B. Lactobacillemia 

report of nine cases, important clinical and therapeutic considerations. 

American Journal of Medicine 64, 808- 813, 1978. 

BENGMARK, S. Ecological control of the gastrointestinal tract. The hole of 

probiotic flora. Gut, v.42,  2-7, 1998. 

BERG, R. D. Bacterial Translocation From Gastrointestinal Tract. Trends in 

Microbiology vol.3 nº 4, 149-154, 1995. 

BERG, R. D. Promotion of the translocation of enteric bacteria from the 

gastrointestinal tract of mice by oral treatment with penicillin, clindamycin, 

or metronidazole. Infect. Immun. 33, 851-861, 1981. 

BERG, R. D. The intestinal microflora in health and disease, Academic 

Press 333-352, 1983. 

BERG, R. D. Translocation and the indigenous gut flora. Scientif basis of 

probiotic concept, 55-85, 1992. 

BERG, R. D., BERNASCONI, P., FOWLER, D., GAUTREAUX, M. Inhibition 

of Cândida albicans translocation from the gastrointestinal tract of mice 



 86

by oral administration of Saccharomices boulardii. Journal Infect. Dis. 

168, 1314-1318, 1993. 

BERG, R. D., GARLINGTON, A. W. Translocation of certain indigenous 

bacteria from the gastrointestinal tract to mesenteric lymph nodes and 

other organs in a gnotobiotic mouse model. Infection and Immunity 23, 

403-411, 1979. 

BERG, R. Inhibition of Escherichia coli translocation from the gastrointestinal 

tract by normal cecal flora in gnotobiotic or antibiotic decontaminated 

mice. Infect. Immun 29, 1073-1081, 1980. 

BERNET, M.F., BRASSART, D., NEESER, J.R. AND SERVIN, A.L. 

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell 

lines and inhibits cell attachment and cell invasion by enterovirulent 

bacteria. Gut 35, 483–489, 1994. 

BERNET-CAMARD, M.-F., LIEVIN, V., BRASSART, D., NEESER, J.-R., 

SERVIN, A.L., HUDAULT, S. The human Lactobacillus acidophilus strain 

LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro 

and in vivo. Appl. Environ. Microbiol. 63, 2747–2753, 1997. 

BEVILACQUA, L., OVIDI, M., DI MATTIA, E., TROVATELLI, L. D., 

CANGANELLA, F. Screening of Bifidobacterium strains isolated from 

human faeces for antagonistic activities against potentially bacterial 

pathogens. Microbiological Research, 158, 179-185, 2003. 

BEZIRTZOGLOU, E. The intestinal Microflora During the first weeks of life. 

Anaerobe 3, 173-177, 1997. 

BORBA, L. M., CASTRO, L. C.V.,.FANCESCHINE, S. C. C., FERREIRA, C. 

L. L. F. Composição do leite humano e microbiota predominantemente 

bífida de lactente em aleitamento materno exclusivo. Nutrire, v. 25, nº1, 

135-154, 2003.  

BORRIELLO, S. P., HAMMES, W. P., HOLZAPFEL, W., MARTEAU, P., 

SCHRENMEIR, J., VAARA, M., VALTONEN, V. Safety of Probiotics That 

Contain Lactobacilli or Bifidobacteria. Clinical Infectious Diseases 36, 

775-780, 2003. 

BROOK, I., MACVITTIE, T.J., and WALKER, R. I., Recovery of aerobic and 

anaerobic bacteria from irradiated mice. Infection and Immunity; 46: 

270–271, 1984 



 87

BROOKS, G. F., BUTEL, J. S. &amp;amp; MORSE, S. A. Microbiologia Médica, 21 

ed., Rio de Janeiro: Guanabara Koogan S.A., p. 117-141, 2000. 

BRUNO, F.A., SHAH, N.P. Inhibition of pathogenic and putrefactive 

microorganisms by Bifidobacterium sp. Milchwissenschaft, 57, 617–

621, 2002. 

BUYNAK, J. D., Understanding the longevity of the ?-lactam antibiotics and 

antibiotic/ ?-lactamase inhibitor combinations, Biochemical 

Pharmacology, 8890: 11-22, 2005. 

BYEZKOWSKI, J., GESSNER, T., Biological role of superoxide íon-radical. 

International Journal of Biochemistry, 20, 569-580, 1988. 

CHARTERIS, W. P., KELLY, P. M., MORELLI, L., &amp;amp; COLLINS, J. K, 

Selective detection, enumeration and indentification of potentially 

probiotic Lactobacillus and Bifidobacterium species in mixed bacterial 

population. International Journal of Food Microbiology 35, 1-27. 

1997. 

CHARTERIS, W. P., KELLY, P. M., MORELLI, L., COLLINS, J. K. Antibiotic 

susceptibility of potentially probiotic Bifidobacterium isolates from the 

human gastrointestinal tract. Let. Appl. Microbiol., v. 26, 333-337, 1998. 

CHRISTIAN, S.S, CHRISTIAN, J. F., The cephalosporin antibiotic. Elsevier 

Science, 1068-607, 168-174,  1997. 

CHULADA, P.C., ARABES S.J. Jr,  DUNSON, D., ZELDIN, D.C., Breast-

Feeding and the prevalence of  asthma and wheeze in children:analyses  

from the third National Healt and Nutrition Examination Survery. Allergy 

clin Immunol, v. 111, p.328-336, 2003. 

CLEVELAND, J., MONTVILLE, T. J., NES, I. F., CHIKINDAS, M. L. 

Bacteriocins: safe, natural antimicrobials for food preservation. 

International Journal of Food Microbiology, 71, 1-20, 2001. 

COCONNIER, M.H., LIEVIN, V., BERNET-CAMARD, M.F., HUDAULT, S. 

AND SERVIN, A.L. Antibacterial e.ect of the adhering human 

Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 41, 

1046–1052, 1997. 

COLLADO, M. C., HERNANDEZ, M., SANZ, Y. Production of Bacteriocin-

Like Inhibitory Compounds by Human Fecal Bifidobacterium Strains. 

Journal of Food Protection vol 68, nº5 pp 1034-1040, 2005a. 



 88

COLLADO, M.C., GONZÁLEZ, A., GONZÁLEZ, R., HERNÁNDEZ, M., 

FERRÚS, M.A., SAZ, Y., Antimicrobial peptides are among the 

antagonistic metabolites produced by Bifidobacterium against 

Helicobacter pylori. International Journal of Antimicrobial Agents, 25, 

p. 385-391, 2005b. 

COLLINS, M.D. e GIBSON, G.R. Probiotcs, prebiotics and synbiotics: 

approaches for modulating the microbial ecology of the gut. Am J. Clin. 

Nutr., v69 (suppl), p. 1052S-1057S, 1999. 

COMMANE, D., HUGHES, R., SHORTT, C., ROWLAND, I. The potential 

mechanisms involved in the anti-carcinogenic action of probiotics. 

Mutation Research 591, 276-289, 2005. 

CONDE, M. R. G. Translocação e desaparecimento de células viáveis de 

Lactobacillus acidophilus em baço, fígado, rins e coração de ratos. 

Universidade Federal de Viçosa, 2001 56p. (Tese MS) 

COUTSOUDIS, A., PILLARY, K., SPOONER, E., KUHN, L., COOVADIA, 

H.M Influence of infant-feeding patterns on early mother-to-chil 

transmission of HIV-1, 2003. In: American Academic Of Pediatrics. 

Breastfeeding and the use of human milk, Pediatrics, v. 115, nº2, 2005. 

CROCIANI, F., ALESSANDRINI, A, MUCCI, M. M . BIAVATI, B., Degradation 

of complex carbohydrates by Bifidobacterium spp. International Journal 

of Food Microbiology 24, 199-210, 1994. 

DANIELSEN, M; WIND, A. Susceptibility of Lactobacillus ssp. to antimicrobial 

agents. International Journal od Food Microbiology  82, 1-11, 2003. 

DEITCH, E. A. Multiple organ failure: pathophysiology and potencial future 

therapy. Ann. Surg. 216, 117-134, 1992. 

DUFFY, L. C., ZIELEZNY, M. A., RIEPENHOFF-TALTY, M., DRYJA, D., 

SAYAHTAHERI-ALTAIE, S., GRIFFITHS, E., RUFFIN, D., BARRETT, 

H., ROSSMAN, J., OGRA, P.L. Effectiveness of Bifidobacterium bifidum 

in mediating the clinical course of murine rotavirus diarrhea. Pediatr. 

Res., 35: 690-695, 1994. 

DUGGAN, C., GANNON, J., WALKER, W. A., Protective nutrients and 

funcional foods for the gastrointestinal trac. American Journal of 

clinical nutrition, 75, p. 789-808, 2002. 



 89

EIZAGUIRRE, I., URKIA, N. G., ASENSIO, A. B., ZUBILAGA, P., VIDALES, 

C., ARENZANA, J. M. G., ALDAZABAL, P., Probiotic suplementation 

reduces the risk of bacterial translocation in experimental short bowel 

syndrome. Journal of Pediatric Surgery vol 37, nº 5, p.699-702, 2002. 

FERREIRA, C. L. L. F. Prebioticos e Probióticos: Atualização e 

Prospecção Ed. Suprema Gráfica e Editora, 1ª ed, Viçosa-MG, 2003. 

FLEMING, H. P., ETCHELLS, J.L., COSTILOW, R.N., Microbial inhibition by 

na isolate of Pediococcus from cucumber briner. Applied Microbiology 

;30(6):1040-2, 1975. 

FOOKS, L. J ., GIBSON, G. R., Probiotics as modulators of the gut flora. Br. 

J. Nutr. 88, 39-49, 2002. 

FOOKS, L. J., FULLER, R., GIBSON, G. R Prebiotics, probiotics and human 

gut microbiology. International Dairy Journal, 9, 53-61, 1999. 

FOOKS, L. J., GIBSON, G. R., Mixed culture fermentation studies on the 

effects of synbiotics on the human intestinal pathogens Campylobacter 

jejuni and Escherichia coli, Anaerobe, 9: 231-242, 2003. 

FORESTIER, C., DE CHAMPS, C., VATOUX, C. AND JOLY, B. Probiotic 

activities of Lactobacillus casei rhamnosus: in vitro adherence to 

intestinal cells and antimicrobial properties. Res. Microbiol. 152, 167–

173, 2001. 

FUJIWARA, S., HASHIBA, H., HIROTA, T., FORSTNER, J. F., 

Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria 

which prevents the binding of enterotoxigenic Eschericchia coli to 

gangliotetraosylceramide. Applied end Envirommental Microbiology, 

63, 506-512, 1997. 

FULLER, K. G., BERG, R. D., Microflora Control and its Applications to the 

Biomedical Sciences (Wostmann, B. S., ed), pp. 195-198, Alan R. Liss 

1985. In: BERG, R. D. Bacterial translocation from the gastrointestinal 

tract. Trends in Microbiology 149, v. 3. nº 4, 1995. 

FULLER, R. History and development of probiotics. In: R Fuller (Ed) 

Probiotics. The Science basis. New York. Chapman and hall,  p. 111-

144, 1992.  



 90

GAGNON, M., KHEADR, E. E., LE BLAY, G., FLISS, I. In vitro inhibition of 

Eschericchia coli O157:H7 by bifidobacterial strains of human origin. 

International Journal of Food microbiology, 92, 69-78, 2004. 

GARNEAU, S., MARTIN, N. I., VEDERAS, J. C. Two-peptide bacteriocins 

produced by lactic acid bactéria. Biochimie, 84, 577-592, 2002. 

GASSER, F. Safety of lactic-acid bacteria and their occurrence in human 

clinical infections. Bulletin de L’Istitut Pasteur, 92: 45-67. 1994. 

GAUTREAUX, M. D., DEITCH, E. A, BERG, R. D  Microecol. Ther 20, 31-

34, 1990. 

GAUTREAUX, M. D., DEITCH, E. A., BERG, R. D., Infect Immun 62, 2874-

2884, 1993. 

GIBSON, G. R., ROBERFROID, M. B. Dietary Modulation of the Human 

Colonic Microbiota: Introducing the Concept of Prebiotics. Journal of 

Nutrition 125, 1401-1412 1995. 

GIBSON, G. R., WANG, X. Regulatory effects of Bifidobacteria on the growth 

other colonic bacteria. Journal of Applied Bacteriology 7, 412-420, 

1994. 

GIUGLIANI, E. R. J. Rede Nacional de Bancos de Leite Humano do Brasil: 

Tecnologia para Exportar. Jornal de Pediatria v. 78, nº3, 2002. 

GOLDING J, Unnatural constituints of breast milk: medication, lifestyle, 

pollutants, viruses. Early Human Development, v. 49: S29-S43, 1997. 

(Suppl.). 

GOMES, A. M. P., MALCATA, F. X. Bifidobacterium spp. and Lactobacillus 

acidophilus biological, biochemical, technological and therapeutical 

properties relevant for use as probiotics. Trends in Food Science &amp;amp; 

Technology 10, 139-157, 1999. 

GONZÁLEZ-MARTÍNEZ, B. E.  TREVIÑO, M. G., JIMÉNEZ-SALAS, Z. 

Bacteriocinas de probióticos. Revista de la Facultad de Salud Pública 

y Nutrición, Vol 4 No.2 , 2003.  

GOODMAN, L. S.; GILMAN, A. As bases farmacológicas da terapêutica. 

8a ed. Rio de Janeiro: Guanabara Koogan, 1991. 1232p. 

GRIFFIN, I. J., DAVILA, P. M., ABRAMS, S. A., Non-digestible 

oligosaccharides and calcium absorption in girls with adequates calcium 

intakes, British Journal of Nutrition, 87, 187-191, 2002. 



 91

GUARNER, C., RUNYON, B. A., YOUNG, S., HECK, M., SHEIKH, M. Y. 

Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats 

with ascites. Journal of Hepatology, 26, 1372-1378, 1997. 

GUARNER, C., SORIANO, G., TOMAS, A., BULBENA, O., NOVELLA, M., 

BALANZO, J., VILARDELL, F., MOURELLE, M., MONCADA, S. Incresed 

serum nitrite and nitrate in patients with cirrhosis of the liver: relationship 

to endotoxemia. Hepatology, 18, 1139-1143, 1993. 

GUARNER, F., MALAGELADA, J. R., Gut flora in health and disease. 

Lancet, 361, 512-519, 2003. 

GUYTON, A. C. Fisiologia Humana, 6. ed., Rio de Janeiro: Guanabara 

Koogan, 348p, 1988. 

GUYTON, A. C. Fisiologia Humana, 9. ed., Rio de Janeiro: Guanabara 

Koogan, 1013, 1997. 

HARSHARNJIT, S. GILL. Probiotics to enhance anti-infective defences in the 

gastrointestinal tract. Best Practive &amp;amp; Research Clinical 

Gastroenterology Vol 17, Nº 5, pp 755-773, 2003 

HATA, D., YOSHIDA, A, OHKUBO, H., Meningitis caused by Bifidobacterium 

in infant.  Pediatr. Infect. Dis. J., v. 7, 669-671, 1988. 

HEINIG, M. J., Host defense benefits of breastfeeding for the infant effect of 

breastfeeding duration and exclusivily. Pediatr. Clin. North. Am. 48, 

105-123, 2001. 

HILTON, E., RINDOS, P., &amp;amp; ISENBERG, H.D Lactobacillus GG vaginal 

suppositories and vaginitis. Jornal of Clinical Microbiology, 33, 1433. 

1995. 

HOYOS, A. B. Reduced incidence of necrotizing enterocolitis associated with 

enteral administration of Lactobacillus acidophilus and Bifidobacterium 

infantis to neonates in an intensive care unit. International Jornal of 

Infecctious Diseases, 3, 197-202. 1999. 

HUIS IN´TVELD, J.H.J., SHORTT, C. Selection criteria for probiotic 

microrganisms. In: LEEDS, A.R., ROWLAND, I.R. Ed . Gut Flora and 

Healthc – past, present and future. Internacional Congress and 

Symposium 219, Royal Society of Medicine Press Limited  p.27-36.1996. 

IBRAHIM, S., BEZKOROVAINY, A., Inhibition of Escherichia coli by 

bifidobacteria. Journal of Food Protection, 56, 713-715, 1993. 



 92

ISHIBASHI, N., YAMAZAKI, S. Probiotics and Safety. Journal Clin Nutr 73 

(suppl):465S-70S, 2001. 

ISOLAURI, E. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73, 444-

450, 2001. 

ISOLAURI, E., ARVOLA, T., SUTAS, Y, MOILANEN, E., &amp;amp; SALMINEN, S. 

Probiotics in the management of atopic eczema. Clinical and 

experimental allergy, 30, 1604-1610. 2000. 

JUNIOR, M. A. S, FERREIRA, E. S, CONCEIÇÃO, G. C.,  Betalactamases 

de spectro ampliado (ESBL): um importante mecanismo de resistência 

bacteriana e sua detecção no laboratório clínico. NewsLab, edição 63, 

2004. 

KABIR, A. M.., AIBA, Y., TAKAGI, A, KAMIYA, S., MIWA, T., KOGA, Y. 

Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic 

murine model. Gut, 41, 49-55, 1997. 

KALLIOMAKI, M., SALMINEN, S., ARVILOMMI, H., KERO, P., KOSKINEN, 

P., ISOLAURI, E., Probiotics in primary prevention of atopic disease: a 

randomised placebo-controlled trial. Lancet, 357. 1076-1079, 2001 

KASHKET, E. R., Bioenergetics of lactic acid bactéria: Cytoplasmic pH and 

osmotolerance. FEMS Microbiology Reviews, 46, 233-244, 1987. 

KHEADR, E., BERNOUSSI, N., LACROIX, C., FLISS, I. Comparison of the 

sensibility of commercial trains and infant isolates of bifidobacteria to 

antibiotics and bacteriocins. International Dairy Journal 14, 1041-1053, 

2004. 

KIM, K, PICKERING, K, DUPONT, H.L, SULLIVAN, N, WILKINS, T. In vitro 

and in vivo neutralizing activity of human colostrum and milk against 

purified toxins A and B of Clostridium dificile. J Infect Diseases, v. 150, 

57-62, 1984. 

KLAENHAMMER, T. R., Bacteriocins of lactic acid bactéria. Biochemie 70, 

337-349, 1988. 

KLEIN, G., PACK, A., BONAPARTE, C. AND REUTER, G. Taxonomy and 

physiology of probiotic lactic acid bacteria. International Journal of 

Food Microbiology 41, 103-125, 1998. 



 93

KOPP-HOOLIHAN, L, Prophylactic and therapeutic uses of probiotics: A 

review. Journal of American Dietetic Association, 101, 229-238 quiz 

239-241, 2001. 

KOROIKOVAS, A.; BURCKHALTER, J. H. Química farmacêutica. Rio de 

Janeiro: Guanabara Koogan,1988. 783p. 

KUNZ C, RODRIGUEZ-PALMERO M, KOLETZKO B, JENSEN R. Nutritional 

and biochemical properties of human milk, part I: general aspects, 

proteins and carbohydrates. Clin Perinatol, v. 26, 307-333, 1999. 

LAWRENCE, R.A, LAWRENCE, R.M. Breastfeeding: A Guide for the Medical 

Profession. St Louis, 1999. 

LAZDUNSKI, C.J. Pore-forming colicins: synthesis, extracellular release, 

mode of action, immunity. Biochimie 70, 1291–1296, 1988. 

LEHTO, E.M. AND SALMINEN, S.J. Inhibition of Salmonella typhimurium 

adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture 

supernate: only a pH effect? FEMS. Immunol. Med. Microbiol. 18, 125–

132, 1997. 

LIÉVIN, V., PEIFFER, I., HUDAULT, S., ROCHT, F., BRASSART, D., 

NEESER, J. R., SERVIN, A.L. Bifidobacterium strains from resident 

infant human gastrointestinal microflora exert antimicrobial activity. Gut, 

47, 646-652, 2000. 

LIM,  K. S.,  HUH,  C. S.  AND  BAEK, Y. J, Antimicrobial susceptibility of 

bifidobacteria.  J.  Dairy   Sci.  76, 2168-2174. 1993.   

LIN, S. Y., CHEN, C. T., Reduction of cholesterol by Lactobacillus 

acidophilus in culture broth. Journal Food Drug Anal., 8, 97-102, 2000. 

LJUNGDAHL, M., LUNDHOLM, M., KATOULI, M., et al. Bacterial 

translocation in experimental shock is dependent on the strains in the 

intestinal flora. Scandinavian Journal of Gastroenterology; 35: 389–

397, 2000. 

LUCAS, A, COLE, T. J. Breast milk and neonatal necrotising enterocolitis. 

Lancet, 336: 1519-1523, 1990. 

MA, L., DEITCH, E., SPECIAN, R., STEFFEN, E., BERG, R., Translocation 

of Lactobacillus murinus from the gastrointestinal tract. Curr. Microbiol, 

20, 17-184, 1990. 



 94

MACKIE, R. I., SGHIR, A., GASKINS, H. R. Developmental microbial ecology 

of teh neonatal gastrointestinal tract. Am. J. Clin. Nutr., v.69, 1035S-

1045S, 1999. 

MAEJIMA, K., DEICH, E. A and BERG, R. D. Promotion by burn stress of the 

translocation of bacteria from the gastrointestinal tracts of mice. Arch. 

Surg, 119, 166-172, 1984. 

MAKRAS, L., DE VUYST, L. The in vitro inhibition of Gram-negative 

pathogenic bactéria by bifidobacteria is caused by the production of 

organic acids. International Dairy Journal, 2005. 

MAN, J.C. DE; ROGOSA, M.; SHARPE, M.E,. A medium for the cultivation of 

Lactobacilli. Journal of Applied Bacteriology, v.23, p.130-135, 1960. 

MASTROMARINO, P., BRIGIDI, P., MACCHIA, S., MAGGI, L., PIROVANO, 

F., TRINCHIERI, V., CONTE, U. AND MATTEUZZI, D. Characterization 

and selection of vaginal Lactobacillus strains for the preparation of 

vaginal tablets. J. Appl. Microbiol. 93, 884–893, 2002. 

MATTILA-SANDHOLM, T., SALMINEN, S. Up-to-date on probiotics in 

Europe. Gastroenterol. Int. 11, 8–16. 1998 

MAY, J.T., Human milk- tables of the antimicrobial factores and 

microbiological contaminants relevant to human milk banking, 1998. 

MEGHROUS, J., EULOGE, P., JUNELLES, A. M., BALLONGUE, J., 

PETITDEMANGE, H. Screening of Bifidobacterium strains for bacteriocin 

production. Biotechnol. Lett. 12, 575-580, 1990. 

MICHETTI, P., DORTA, G., WIESEL, P.H., BRASSART, D., VERDU, E., 

HERRANZ, M., FELLEY, C., PORTA, N., ROUVET, M., BLUM, A.L., 

CORTHESY-THEULAZ, I.. Effect of whey-based culture supernatant of 

Lactobacillus acidophilus ( johnsonii) La1 on Helicobacter pylori infection 

in humans. Digestion 60, 203–209, 1999. 

MIDOLO, P. D., LAMBERT, J. R., HULL, R., LUO F., GRAYSON, M. L. In 

vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and 

lactic acid bacteria. J. App. Bacteriol., 79: 475-479, 1995. 

MILLER, L. G., FINEGOLD, S. M,. Antibacterial sensibility of Bifidobacterium 

(Lactobacillus bifidus). Journal of Bacteriology, 93, 125-130, 1967. 

MITSUOKA, T. Bifidobacteria and their role in human health. Journal of 

Industrial Microbiology 6, 263-268, 1990. 



 95

MITSUOKA, T. Intestinal flora and human health. Asia Pacific. J. Clin. Nutr. 

V.1, p.2-9, 1996. 

MITSUOKA, T. Microbes in the intestine- our lifelong partners Yakult Honsha 

Co., Std Tokyo, 1989, 104 p. 

MITSUOKA, T. Recente trends in research on intestinal flora. Bididobacteria 

and Microflora, v.1, p.3-24, 1982. 

MITSUOKA, T., Intestinal bacteria and health, Tokyo: Harcourt Brace 

Jovarnovich Japan, 1978, 208p. 

MITSUOKA, T., Intestinal flora and aging. Nutr. Rev., v.50, 438-446, 1992. 

MODLER, H. W. Bifidogenics Factors – Sources, metabolism and 

Applications. International Dairy Journal 4, 383-407, 1994. 

MONTVILLE, T. J., WINKOWSKI, K., LUDESCHER, R. D., Models and 

mechanisms for bacteriocin action application. International Dairy 

Journal, 5, 797-814, 1995. 

MOREHOUSE, J., SPECIAN, R., STEWART, J., BERG, R. D. Promotion of 

translocation of indigenous bactéria of mice from the GI trat by oral 

ricinoleic acid, Gastroenterology 91, 673-682 (1986). 

MOUBARECK, C., GAVINI, F., VAUGIEN, L., BUTEL, M. J., DOUCET-

POPULAIRE, F. Antimicrobial susceptibility of bifidobacteria. Journal of 

Antimicrobial Chemotherapy, 55, 38-44. 2005. 

MURRAY, P. R., ROSENTHAL, K. S., KOBAYASHI, G. S. &amp;amp; PFALLER, M. A. 

Microbiologia Médica, 3 ed., Rio de Janeiro: Guanabara Koogan S.A., p. 

135-141, 2000. 

NAKAZAWA, T., KANEKO, K., TAKAHASHI, H., INOUE, S. Neonatal 

meningitis caused by Bifidobacterium breve. Brain &amp;amp; Development, 

v.18, 160-162, 1996. 

NEWMANN, E., FERREIRA, C. L. L. F. Lactobacillus acidophilus as dietary 

adjunct “in vitro” susceptibility to gastric juice, bile salts, lysozime and 

chemotherapeutic agents. Revista de Microbiologia, v.26, p.59-65, 

1995. 

NICAS, T. I., COLE, C. T., PRESTON, D. ª, NAGARAJAN, R., Activity of 

glicopeptides agaisnst vancomycin-resistant Gram positive bactéria. 

Antimicrobial Agents and Chemotherapy 33, 1477-1481, 1989. 



 96

OGAWA, M., SHIMIZU, K., NOMOTO, K., TAKAHASHI, M., WATANUKI, M., 

TANAKA, R., TANAKA, T., HAMABATA, T., YAMASAKI, S. AND 

TAKEDA, Y. Protective effect of Lactobacillus casei ssp Shirota on Shiga 

toxin- producing Escherichia coli O157:H7 infection in infant rabbits. 

Infect. Immun. 69, 1101–1108, 2001. 

OZBAS, Z. Y., AYTAC, S. A. Behaviour of Yersinia enterocolitica and 

Aeromonas hydrophila in yogurt made with probiotic bactéria: 

Bifidobacterium infantis and Lactobacillus acidophilus. Milchwiss, 50, 

626-629, 1995. 

PAIVA NETTO, J. V. Antibióticos e quimioterápicos em medicina veterinária. 

Rio de Janeiro: Livraria Atheneu, 1989. 181p. 

PATHMAKANTHAN, S.,  MEANCE, S., &amp;amp; EDWARD CA. Probiotics: a review 

of human studies to date and methodological approaches. Medical 

Ecology in Health and desease 10-13. 2002 

PERDIGON, G., FULLER, R., RAYA, R. Lactic acid bactéria and their effect 

on the immune system. Curr. Issues Intest. Microbiol, 2, 27-42, 2001. 

PEREZ, P.F., MINNAARD, J., ROUVET, M., KNABENHANS, C., 

BRASSART, D., DE ANTONI, G.L. AND SCHI.RIN, E.J. Inhibition of 

Giardia intestinalis by extracellular factors from lactobacilli: an in vitro 

study. Appl. Environ. Microbiol. 67, 5037–5042, 2001. 

PODOLAK, P. K., ZAYAS, J. F., KASTNER, C. L., FUNG, D. Y. C. Inhibition 

of Listeria monocytogenes and Escherichia coli O157:H7 on beef by 

application of organic acids. Journal of Food Protection, 59, 370-373, 

1996. 

QUINTILIANI, R. Jr, SAHM, D. F, COURVALIN, P, Mechanism of resistence 

to antimicrobial agents, 1999. In: MONBARECK, C., GAVINI, F., 

VAUGIEN, L., BUTEL, M. J, POPULAIRE-DOUCET, F. Antimicrobial 

susceptibility of bifidobacteria. Journal of Antimicrobial Chemotherapy 

55, 38-44. 2005.  

RAMOS, M. P.P, CUNHA, L.. R., MALDONADO, I. C. S. C., CARLOS, I. Z., 

FERREIRA, C. L. L. F. Influência da ingestão de Bifidobacterium breve 

na determinação das citocinas IL-4, e IL-6, INF?, PNF? e compostos 

intermediários do nitrogênio (NO) e do oxigênio H2O2, 2006 no prelo. 



 97

RENNE, M., KALLIOMAKI, M., ARVILOMMI, H. Effect of probiotic and 

breastfeeding on the Bifidobacterium and Lactobacillus/Enterococcus 

microbiota and humoral immune responses. Journal of Pediatrics, 

v.147, 186-191, 2005. 

RIORDAN, K. O., FITZGERALD, G. F., Determination of genetic diversity 

within the genus Bifidobacterium and estimation of chromosomal size. 

FEMS Microbial. Lett., v. 156, p.259-264, 1997. 

ROBREDO, B., SINGH, K. V., BAQUERO, R., MURRAY, B. E., TORRES, C. 

Vancomycin-resistant enterococci isolated from animals and food. Int. J. 

Food Microbiol. 54, 197–204, 2000. 

SAARELA, M., MOGENSEN, G.,FONDEN, R., MATTO, J., MATTILA-

SANDHOLM, T., Probiotic bacteria: safety, functional and technological 

properties. Journal of Biotechnology 84, 197-215, 2000. 

SAAVEDRA, J. M., BAUMAN, N. A., OUNG, I., PERMAN, J. A., YOLKEN,  

R. H. Feeding of Bifidobacterium bifidum and Streptococcus 

thermophilus to infants in hospital for prevention of diarrhoea and 

shedding of rotavirus. Lancet., 344: 1046-1049, 1994. 

SALMINEN, S., ISOLAURI, E., SALMINEN, E., Clinical uses of probiotics for 

stabilizing the gut mucosal barrier: Successful strains and future 

challenges. Antonie Van Leuwenhoek, 70: 347-358, 1996. 

SATTERWHITE, T. K., EVANS, D. G., DUPONT, H. L., et al. Role of 

Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet; 

181–184, 1978. 

SCARDOVI, V. In: Sneath PHA, Mair NS, sharpe me AND Holt JG, eds. 

Bergey’s Manual of Systematic Bacteriology, Baltimore, MD: Williams 

and Wilkins.,vol: 1418-1434. 1986 

SCHIFFRIN, E. J., BRASSART, D., SERVIN, A. L., ROCHAT, F., DONNET-

HUGHES, A . Imune modulation of bloood leukocytes in humans by lactic 

acid bacteria: criteria for strains selection. Am. J. Clin. Nutr. 66, 515-

520, 1997. 

SEEHOFER, D., RAYES, N., SCHILLER, R., STOCKMANN, M., MULLER, 

A.. R., STOCKMANN, M., et al Probiotics partly reverse incresed 

bacterial translocation after simultaneous liver resection and colonic 

anastomosis in rats. Journal of Surgery Research 117, 262-271, 2004. 



 98

SERVIN, A. L., Antagonistic activities of lactobacilli and bifidobacteria against 

microbial pathogens. Microbiology Reviews, 28, 405-440, 2004.  

SGORBATI, B., BIAVATI, B. E PALENZONA, D. The genus Bifidobacterium. 

Em Wood, B. J. B. e Holzapfel, W. H. (eds), The Lactic Acid Bacteria Vol. 

2. The Genera of Lactic Acid Bacteria, capítulo 8, pp. 279-306, Blackie 

Academic, Londres, RU. 1995. 

SHORTT, C., The probiotic century: historical and current perspectives. 

Trends in Food Science and Technology 10, 411-417, 1999. 

SHU, Q., ZHOU, J. S.., RUTHERFURD, K. J., BIRTLES, M. J., PRASAD, J., 

GOPAL, P. K., GILL, H. S. Probiotic lactic acid bactéria (Lactobacillus 

acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium 

lactis HN019) have no adverse affects on the health of mice. 

International Dairy Journal 9, 831-836, 1999. 

SILVA, C.H.P.M., Bacteriologia: um texto ilustrado, Teresópolis: Eventos, p. 

107-119, 1999. 

SILVA, T. M. O que são radicais livres. 2003.  Acesso em 15  Fev. 2006. 

Disponível em 

&lt;www.medstudents.com.br/content/resumos/trabalhos_radicais_livres&gt;. 

SINGHAL, A, FAROOQI, I.S,  O’RAHILLY, S., COLE, T.J, FEWTRELL, M., 

LUCAS, A. Early nutrition and leptin concentrations in later life. Am clin 

Nutr, v. 75, 993-999, 2002 

SLOCUM, M. M., SITTIG, K. M., SPECIAN, R. D. Absence of intestinal bile 

promotes bacterial translocation. American Surgeon 58, 305-310, 1992. 

SNIJDERS, J. M., VAN LOGTESTIJN, J. G., MOSSEL, D. A. A., 

SMULDERS, F. J. M. Lactic acid as a decontaminant in slaughter and 

processing procedures. Veterinary Quarterly, 7, 27-282, 1985. 

SOUZA, D. F. M. C.; FERREIRA, C. L. L. F. ; SOUZA, A. V. C., COSTA, N. 

M. B., YBARRA, L. M., AZEREDO, E. M. C. Translocação de 

Lactobacillus acudiphilus em ratos alimentados com dieta rica em 

colesterol e ácido cólico suplementada com probiótico. Ciência e 

Tecnologia de Alimentos, Campinas, v. 24, n. 04, p. 522-526, 2004. 

 



 99

SPAETH, G., BERG, R. D., PPECIAN, R. D., AND DEITCH, E. A, Food 

without fiber promotes bacterial translocation from the gut. Surgery, 108, 

240-247, 1990. 

SPAETH. G., GOTTWALD, T., SPECIAN, R. D., MAINOUS, M. R., BERG, R. 

D., DEITCH, E. A. Secretory immunoglobulin A, intestinal micin, and 

mucosal permeability in nutritionally-induced bacterial translocation in 

rats. Ann. Surg. 220, 798, 1994. 

SREEKUMAR, O., HOSONO, A. The antimutagenic properties of a 

polysaccharide produced by Bifidobacterium longum and its cultured milk 

against some heterocyclic amines. Can. J. Microbiol, 44, 1029-1036, 

2003. 

STEFFEN, E. K., BERG, R. D., and DEITCH, E. A. J. Infect. Dis 157, 1032-

1037, 1988. 

STRUS, M., PAKOSZ, K., GOSCINIAK, H., PRZONDO-MORDARSKA, A., 

ROZYNEK, E., PITUCH, H., MEISEL-MIKOLAJCZYK, F. AND HECZKO, 

P.B. Antagonistic activity of Lactobacillus bacteria strains against 

anaerobic gastrointestinal tract pathogens (Helicobacter pylori, 

Escherichia coli, Campylobacter jejuni, Clostridium difficile). Med. Dosw. 

Mikrobiol. 53, 133–142, 2001. 

SUZUKI, T., ITOH, K., KANEKO, T., SUZUKI, H. Inhibition of bacterial 

translocation from the gastrointestinal tract of mice by oral admistration of 

a culture condensate of Bifidobacterium longum. J. Vet. Med. Science. 

59 (8): 665-669, 1997. 

SWANK, G. M., DEITCH, E. A., Role of the gut in multiple organ failure: 

Bacterial translocation and permeability changes. World. J. Surg. 20, 

411-417, 1996. 

SZAJEWSKA, H., MRUKOWICZ, J. Z, Probiotics in the tratament and 

prevention of acute infectious diarrhea in infants and children. Jornal of 

Pediatric Gastroenterology and Nutrition, 33, p 17-25 2001. 

TAGG, J. R., DAJANI, A. S., WANNAMAKER, L. W., Bacteriocins of Gram 

positive bacteria. Bacteriol. Rev. 40, 722-756, 1976. 

TANAKA, R.,  AND SHIMOSAKA, K.,  Investigation of the stool frequency in 

elderly who  are bedridden and is improvement by ingesting of bifidus 

yorgut. J. Geriar. 19:577-582, 1982. 



 100

TANNOCK. G. W. Probiotics – a critical review. England: Horizon Scientific 

Press, 1999, p. 5-14, 1999. 

TAVARES, W. Manual de Antibióticos e Quimioterápicos 

Antiinfecciosos. São Paulo: Atheneu, 1990. 

TAVARES, W. Manual de antibióticos e quimioterápicos antiinfecciosos. 

3ª ed. São Paulo: Atheneu, p. 292, 2001. 

TESHIMA, E. Seleção de Bactérias Bífidas Isoladas de Lactentes e 

Modulação da Microbiota Intestinal por Meio de Probióticos, Prebióticos 

e Simbióticos, Universidade Federal de Viçosa, 2001 113p. (Tese DO). 

TESHIMA, E., BORBA, L., RAMOS, M. P. P., CUNHA, L. R., FERREIRA, C. 

L. L. F. Bactérias Bífidas Endógenas Probióticas para Uso em Bancos de 

Leite Humano. I Congresso Mineiro de Alimentação e Nutrição – A 

Ciência por um Brasil sem Fome. 2005. 

TICHACZEK, P. S., NISSEN-MEYER, J., NES, I. F., VOGEL, R. F., 

HAMMES, W. P. Characterization of the bacteriocins curvacin A from 

Lactobacillus curvatum LTH1174 and sakacin P from Lactobacillus sake 

LTH673. Sys. Appl. Microbiol 15, 460-468, 1992. 

TISSIER, H,. Le Bacterium coli et le réaction chromophilr d’ Escherich. C. R. 

Soc. Biol. 51:943, 1899. 

TORTORA G. J, FUNKE B. R, CASE C. L. Microbiologia. Ed. Artes Médicas 

Sul, 6ªed, Porto Alegre, 2000. 

TOSIN I. Avaliação do modo de disseminação da resistência bacteriana a 

antibacterianos nos hospitais brasileiros. São Paulo; s. n; [137] p. 2001. 

TOURÉ, R., KHEADR, E., LACROIX, C., MORONI,  O.,FLISS, I Production 

of antibacterial substances by bifidobacterial isolates from infant stool 

active against Listeria monocytogenes. Journal od Apllied 

Microbiology, 95, 1058-1069, 2003. 

TOZZI, A.E, PEZZOTTI, P., GRECO, D., Does breastfeeding delay 

progression to AIDS in HIV-infected children? AIDS, v.4:1, 293-400, 

1990. 

VASSEUR, C., BAVAREL, L., HEBRAUD, M., LABADIE, J., Effect of osmotic 

alkaline, acid or thermal stresses on the growth and inihibition of Listeria 

monocytogenes. Journal of Applied Microbiology, 86, 469-476, 1999. 



 101

VELRAEDS, M. C., VAN DER MEI, H. C., REID, G., BUSSCHER, H. J. 

Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by 

biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol. 62, 

1958–1963, 1996. 

VIEIRA, G. O., SILVA, L. R., VIEIRA, T. O. Alimentação infantil e morbidade 

por diarréia. J. Pediatr, 79(5), 449-454, 2003. 

WALSH, C. Molecular mechanisms that confer antibacterial drug resistence. 

Nature; 406: 775-81, 2000. 

WELLS CL. Relationship between intestinal microecology and the 

translocation of intestinal bacteria. Antonie van Leeuwenhoek, 58: 87–

93, 1990. 

WELLS, C. L., JECHOREK, R. P., ERLANDSEN, S. L.  Inhibitory effects of 

bile on bacterial invasion of enterocytes: possible machanism for 

increased translocation associated with obstructive jaundice. Critical 

Care Medicine 23, 301-307, 1995. 

WELLS, C. L., MADDUS, M. A.,SIMMONS, R. L. Role of the macrophage in 

the translocation of intestinal bacteria. Archives of Surgery 122, 48-53, 

1987. 

WIEST, R., RATH, H. C. Bacterial Translocation in the Gut. Best Practice &amp;amp; 

Research Clinical Gastroenterology vol 17, nº 73, 397-425, 2003. 

WILLIANS, R., STEHLIN, I., Breast milk or formula: making the right choice 

for your baby, Adapted from FDA consumer, 2005. 

WILMORE, D. W., SMITH, R. J., O’DWYER, S. T., JACOBS, D. O., 

ZIEGLER, T. R., WANG, X. The gut: a central organ after stress. 

Surgery 104, 917-923, 1988.  

WORK GROUP ON BREASTFEEDING AMERICAN ACADEMY OF 

PEDIATRICS. Breastfeeding and the use of human milk. Pediatrics, v. 

100, 1035-1039, 1997. 

WRIGHT, A. V, Regulating the Safety of Probiotics. The European Approach. 

Current Pharmaceutical Design, 11, 17-23. 2005. 

YASID, A. M, ALI, A. M, SHUHAIMI, M., KALAIVAANI, V., ROKIAH, M. Y., 

REEZAL, A. Antimicrobial susceptibility of bifidobacteria. Letters in 

Applied Microbiology 31, 57-62, 2000. 



 102

YASUI, H., Shida, K., Matsuzaki, T. and Yokokura, T. Immunomodulatory 

function of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 383–

389, 1999. 

YILDIRIM, Z., JOHNSON, M. G., Characterization and antimicrobial 

spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium 

bifidum NCFB 1454. Journal Food Protection, 61, 47-51, 1998. 

 YILDIRIM, Z., WINTERS, D. K., JOHNSON, M. G. Purification amino acid 

sequence and mode of action od bifidocin B produced by Bifidobacterium 

bifidum NCFB 1454. Journal of Applied Microbiology, 86, 45-54, 1999. 

YIM HÁ, G., YANG, C. H., KIM, H., CHONG, Y. Case of sepsis caused by 

Bifidobacterium longum. J. Clin. Microbiol., v. 37, 1227-1228, 1999. 

YOLKEN, R.H, PETERSON, J.A VONDERFECHT, S.L., FOUTS, E. T, 

MIDDTHUN, NEWBURG, D.S. Human milk mucin inhibits rotavirus 

replication and prevents experimental gastroenteritis. J. Clin. Invest, v. 

90, p.1984-1991, 1992. 

YOUNG, R. J., HUFFMAN, S., Probiotic Use in Children . Journal Pediatr 

Health Care. 17 p 277-283, 2003. 

ZHOU, J. S, PILLIDGE, C. J, GOPAL, P. K, GILL, H. S.  Antibiotic 

susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium 

strains. International Journal of Food Microbiology  98, 211-217. 2005. 

ZHOU, J. S., SHU, Q., RUTHERFURD, K. J., PRASAD, J., GOPAL, P. K., 

GILL, H. S. Acute oral toxicity and bacterial translocation studies on 

potencially probiotic strains of Lactic acid bactéria.  Food and Chemical 

Toxicology 38, 153-161, 2000a. 

ZHOU, J. S., SHU, Q., RUTHERFURD, K. J., PRASAD, J., GOPAL, P. K., 

GILL, H. S. Safety assessment of potencial probiotic lactic lactic acid 

bacterial strains Lactobacillus rhamnosus HN001, Lb.  acidophilus 

HN017, and Bifidobacterium lactis HN019 in BALB/c mice. International 

Journal of Food Microbiology 56, 87-96, 2000b. 




</field>
	</doc>
</add>